GLP-1 Drugs Cut Psychiatric Hospital Admissions For Schizophrenia By 24%: Study

GLP-1 Drugs Cut Psychiatric Hospital Admissions For Schizophrenia By 24%: Study The study, published Wednesday, was the first to link powerful obesity and diabetes medicine with a reduced likelihood of schizophrenia hospitalization, Bloomberg reported. One of the authors of the study hypothesized that better metabolic health might support “psychiatric stability.” https://kffhealthnews.org/morning-breakout/pharma-and-tech-101526/